A new immune-modulating treatment has shown promising results for treating moderate to severe eczema, delivering fast itch ...

Investing.com -- Hoth Therapeutics Inc (NASDAQ: HOTH) stock rose 2.5% after the clinical-stage biopharmaceutical company announced positive results from its ongoing Phase 2a clinical trial evaluating ...

Understanding the root causes and appropriate interventions is essential for effective and culturally sensitive hair growth management.